Get started
Author

Eliza Del Fiol Manna

Observed name: E. Del Fiol Manna
ORCID: 0000-0002-0090-091X
Observed ORCID: 0000-0002-0090-091X
OpenAlex ID: A5048457649
Advances in Breast Cancer Risk Modeling: Integrating Clinics, Imaging, Pathology and Artificial Intelligence for Personalized Risk Assessment
2023 · Filippo Pesapane, Ottavia Battaglia, et al. · Future Oncology · 28
Hereditary Breast Cancer: Comprehensive Risk Assessment and Prevention Strategies
2025 · Eliza Del Fiol Manna, Davide Serrano, et al. · Genes · 21
PDF
Chemoprevention and Lifestyle Modifications for Risk Reduction in Sporadic and Hereditary Breast Cancer
2023 · Eliza Del Fiol Manna, Davide Serrano, et al. · Healthcare · 14
PDF
Association between Immunohistochemical Expression of Topoisomerase IIα, Her2 and Hormone Receptors and Response to Primary Chemotherapy in Breast Cancer
2006 · Eliza Del Fiol Manna, Luiz Carlos Teixeira, et al. · Tumori Journal · 11
MLH1 promoter hypermethylation and Lynch Syndrome: When to test for constitutional epimutations of MLH1 gene?
2025 · Laura Cazzaniga, Cristina Zanzottera, et al. · Tumori Journal · 6
Expression of immune-related genes and breast cancer recurrence in women with ductal carcinoma in situ
2024 · Elena Guerini-Rocco, Federica Bellerba, et al. · European Journal of Cancer · 6
PDF
Progestin-only implant and breast cancer risk in adolescents and premenopausal women: A systematic review and meta-analysis
2026 · Angela Theresa Zuffo Yabrude, Leila Caroline Souza Reis, et al. · Cancer Epidemiology · 1
Efficacy of immune-oncology combinations versus sunitinib in patients with bone metastases from renal cell carcinoma: A systematic review and meta-analysis of phase III trials with long-term follow-up
2026 · Clara Fish Araujo de Albuquerque, Leila Caroline Souza Reis, et al. · Journal of bone oncology
PDF
Trends and Differences in Breast Cancer Mortality by Race, Region and Age among Brazilian Women between 1996-2024: A Nationwide Ecological Study
2026 · Angela Theresa Zuffo Yabrude, Leila Caroline Souza Reis, et al. · medRxiv
PDF
Access to trastuzumab deruxtecan for HER2-low metastatic breast cancer in Brazil’s Unified Public Health System: A population-impact model.
2026 · Angela Theresa Zuffo Yabrude, Leila Caroline Souza Reis, et al. · Journal of Clinical Oncology
Progestin-only implant and breast cancer risk in adolescents and premenopausal women: A systematic review and meta-analysis.
2026 · Angela Theresa Zuffo Yabrude, Leila Caroline Souza Reis, et al. · Journal of Clinical Oncology
Public-Health Impact of Delayed Access to Neoadjuvant-Adjuvant Pembrolizumab for High-Risk Early-Stage Triple-Negative Breast Cancer in Brazil
2026 · Angela Theresa Zuffo Yabrude, Leila Caroline Souza Reis, et al. · SSRN Electronic Journal
14P Immune signature predicts occult invasion in ductal carcinoma in situ diagnosed by vacuum-assisted breast biopsy
2025 · M. Lazzeroni, F. Conversano, et al. · Immuno-Oncology Technology
Environmental and occupational exposures and the risk of idiopathic pulmonary fibrosis: A systematic review
2021 · Eliza Del Fiol Manna, Giancarlo Pocetta, et al. · Giornale italiano di medicina del lavoro ed ergonomia
Associação entre a expressão imunoistoquimica da topoisomerase II'alfa', HER2 e receptores hormonais e a resposta a quimioterapia primaria em pacientes com cancer de mama
2005 · Eliza Del Fiol Manna
PDF
Carcinomas primários de mama e ovário na mesma paciente: relato de cinco casos Breast and ovary primary carcinoma in the same patient: report of five cases
1999 · Eliza Del Fiol Manna, Marcelo Benedito Mansur Bumlai, et al. · Revista de Ciências Médicas
PDF
Works count: 16
Citation count: 87
H-index: 6
I10-index: 4
Year
Topic
Type